Down Syndrome study links genes to health outcomes for personalized care

A new multiomics study, published in Bio-IT World, found that people with Down syndrome show vastly different health outcomes based on unique molecular signatures. This research means that personalized care plans could replace one-size-fits-all treatments for the genetic condition, moving beyond broad diagnoses to individual biology.